NJ Cannabis Regulations: Local Control and Social Equity Challenges
July 19, 2024
As New Jersey’s cannabis industry continues to evolve, striking a balance between local regulatory control and equitable market access remains crucial. Applicants, especially those from “social equity” backgrounds, face significant challenges due to financial constraints and stringent local regulations. The article by Joshua S. Bauchner and Natalie C. Diaz provides a comprehensive overview of these challenges and offers valuable insights into navigating the complex regulatory environment.
NJLJ: How Will the Federal Reclassification of Marijuana Affect New Jersey’s Cannabis Industry?
June 16, 2024
In a recent article published by the New Jersey Law Journal, the DEA’s proposal to reclassify marijuana from Schedule I to Schedule III marks a significant shift in federal drug policy, acknowledging its medical benefits and potential legal ramifications.
Joshua S. Bauchner, Chair of the Cannabis, Hemp & Psychedelics Practice Group at Mandelbaum Barrett PC, was quoted emphasizing the significance of this step towards acknowledging cannabis’s medical value. He highlights that while rescheduling is a positive development for the industry, the ultimate goal remains declassification to address past injustices and fully normalize cannabis.
NJBIZ Insight: Joshua Bauchner’s Analysis of Highland Park’s Cannabis Legal Battle
May 20, 2024
Joshua Bauchner analyzes the legal intricacies of Highland Park’s cannabis battle. Bauchner underscores the court’s rejection of federal preemption claims and the uphill battle facing opponents. He emphasizes the inevitability of cannabis legalization in New Jersey despite challenges, offering insights into the legal landscape and the industry’s future.
Joshua Bauchner quoted on NJBiz Article: Marijuana reclassification could clear hurdles for NJ businesses
May 6, 2024
In response to the DEA’s recommendation to reschedule marijuana, Joshua Bauchner, emphasized the need for broader reform. Bauchner stated, “While it’s an important step forward in recognizing the long-established medicinal value of cannabis, the ultimate goal is not rescheduling, it’s descheduling.” This underscores the ongoing dialogue surrounding cannabis legislation and the varied viewpoints within the legal community, reflecting the complexities involved in reshaping cannabis policy.
Breaking News: DEA Insider Leaks Hint at Cannabis Reclassification
May 6, 2024
According to insiders, the DEA is considering a reclassification of cannabis. The proposal, yet to undergo White House review, could mark a significant shift in federal cannabis policy. If approved, this move might pave the way for greater research opportunities and potentially alter the landscape of cannabis regulation in the United States.
Joshua S. Bauchner Explores Cannabis DUI Challenges in New Jersey v. Olenowski: Insights from the Karma Koala Podcast
February 7, 2024
Joshua Bauchner, Partner and Chair of Mandelbaum Barrett PC’s Cannabis, Hemp, and Psychedelics Practice Group, shared insights on the Karma Koala Podcast. He discussed the legal and technological challenges in identifying cannabis DUI cases, focusing on the New Jersey v. Olenowski case. Bauchner’s analysis shed light on complex legal intersections and technological limitations.
Joshua S. Bauchner Listed as one of the Top 200 Global Psychedelics Lawyers
February 6, 2024
In the third edition of the Global Top 200 list of Psychedelics Lawyers, Joshua S. Bauchner, Partner and Chair of the Cannabis, Hemp, and Psychedelics Practice Group at Mandelbaum Barrett PC, is newly acknowledged. His inclusion honors his dedication, experience, and impactful contributions to psychedelic law and its industry advancement.
Joshua S. Bauchner Attends the Cannabis Law Section MCLE Programs event, hosted by the New York State Bar Association.
January 29, 2024
Explore the dynamic legal terrain of cannabis, hemp, and psychedelics with Joshua S. Bauchner and Mandelbaum Barrett PC’s expert panelists. Gain invaluable insights into New York and New Jersey’s evolving regulatory frameworks at the recent NYSBA event. Dive deep into compliance and emerging trends.
Law360: Can Off-Duty Cops Use Marijuana?
January 26, 2024
In 2024, Law360 highlights a pivotal case stemming from New Jersey’s legalization of recreational marijuana, which clashed with federal firearm laws. Jersey City’s struggles with enforcing these laws led to a legal battle, triggering controversy over police terminations and accusations of political bias. Joshua S. Bauchner condemned the city’s actions as hypocritical.